Atypical antipsychotics for autism spectrum disorder: a network meta-analysis (Protocol)

Nicolás Meza, Reginald Rees, Camila Micaela Escobar Liquitay, Juan V.A. Franco, Yanina Sguassero, Katrina Williams, Tamara Pringsheim, Valeria Rojas, Eva Madrid

Research output: Contribution to journalArticleResearchpeer-review


Objectives: This is a protocol for a Cochrane Review (intervention). The objectives are as follows:. Primary To assess the comparative efficacy of atypical antipsychotics for irritability through network meta-analysis in children and adults with autism spectrum disorder (ASD). Secondary To assess the safety and efficacy of atypical antipsychotics as medications for core and non-core symptoms in children and adults with ASD.

Original languageEnglish
Article numberCD014965
Number of pages19
JournalCochrane Database of Systematic Reviews
Issue number5
Publication statusPublished - 3 May 2022

Cite this